Chemotherapeutics in the treatment of multiple sclerosis
The likely pathogenic mechanisms of multiple sclerosis (MS) provide a sound rationale for investigating the efficacy of drugs possessing immunosuppressive or immunomodulatory properties. With proven efficacy, safety and tolerability, interferon beta formulations and glatiramer acetate have become th...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2010-09-01
|
| シリーズ: | Therapeutic Advances in Neurological Disorders |
| オンライン･アクセス: | https://doi.org/10.1177/1756285610379885 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|